Corcept Therapeutics, Inc. (CORT)
42.54
+0.06
(+0.13%)
USD |
NASDAQ |
Apr 06, 12:01
Corcept Therapeutics Market Cap : 4.581B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 298.94B |
| Terns Pharmaceuticals, Inc. | 6.085B |
| Integer Holdings Corp. | 2.938B |
| Ultragenyx Pharmaceutical, Inc. | 2.314B |
| ACADIA Pharmaceuticals, Inc. | 3.829B |
Market Cap Related Metrics
| PE Ratio | 52.00 |
| PS Ratio | 6.700 |
| Price to Book Value | 6.986 |
| Price to Free Cash Flow | 35.98 |
| Price | 42.54 |
| Earnings Yield | 1.92% |
| Operating PE Ratio | 113.87 |
| Normalized PE Ratio | 52.00 |